发明名称 |
PREDICTION OF BREAST CANCER RESPONSE TO TAXANE-BASED CHEMOTHERAPY |
摘要 |
The invention relates to methods and kits for the prediction of a likely outcome of chemotherapy in a cancer patient. More specifically, the invention relates to the prediction of tumour response to chemotherapy based on measurements of expression levels of a small set of marker genes. The set of marker genes is useful for the identification of breast cancer subtypes responsive to taxane based chemotherapy, such as e.g. a taxane-anthracycline-cyclophosphamide-based (e.g. Taxotere (docetaxel)-Adriamycin (doxorubicin)-cyclophosphamide, i.e. (TAC)-based) chemotherapy. |
申请公布号 |
EP2041307(A2) |
申请公布日期 |
2009.04.01 |
申请号 |
EP20070785912 |
申请日期 |
2007.07.06 |
申请人 |
SIEMENS HEALTHCARE DIAGNOSTICS GMBH |
发明人 |
GEHRMANN, MATHIAS;VON TOERNE, CHRISTIAN |
分类号 |
C12Q1/68 |
主分类号 |
C12Q1/68 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|